Arch Capital Group Ltd. (BIT:1ACGL)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Investments in Debt Securities	31,341	28,944	24,990	20,508	18,594	19,788
Investments in Equity & Preferred Securities	9,642	9,131	7,060	5,736	6,135	3,763
Other Investments	4,666	2,972	2,226	1,444	2,005	3,304
Total Investments	45,649	41,062	34,278	27,690	26,784	26,873
Cash & Equivalents	983	979	917	855	858.67	906.45
Reinsurance Recoverable	9,044	8,260	7,064	6,564	5,881	4,501
Other Receivables	10,066	8,876	7,456	6,097	5,629	6,052
Deferred Policy Acquisition Cost	1,814	1,734	1,531	1,264	901.84	790.71
Property, Plant & Equipment	-	129	125	123	106.84	115.91
Goodwill	-	571	345	342	344.87	314.63
Other Intangible Assets	1,319	780	386	462	600.12	378.23
Restricted Cash	-	781	581	418	456.1	384.1
Other Current Assets	3,229	2,634	2,367	1,948	1,845	1,411
Other Long-Term Assets	6,684	5,100	3,856	2,227	1,694	1,555
Total Assets	78,788	70,906	58,906	47,990	45,101	43,282
Insurance & Annuity Liabilities	2,286	2,165	1,817	1,734	1,832	1,996
Unpaid Claims	32,089	29,369	22,752	20,032	17,757	16,514
Unearned Premiums	11,625	10,218	8,808	7,337	6,012	4,839
Reinsurance Payable	2,841	2,137	2,000	1,530	1,583	683.26
Current Portion of Leases	-	31	-	-	-	-
Short-Term Debt	-	-	-	-	-	301.09
Long-Term Debt	2,728	2,728	2,726	2,725	2,724	3,017
Long-Term Leases	-	132	156	152	126.71	136.02
Other Current Liabilities	-	115	119	76	54.22	130.38
Other Long-Term Liabilities	4,178	3,191	2,173	1,483	1,456	1,679
Total Liabilities	55,747	50,086	40,551	35,069	31,546	29,295
Preferred Stock, Redeemable	830	830	830	830	830	780
Total Preferred Equity	830	830	830	830	830	780
Common Stock	1	1	1	1	0.65	0.64
Additional Paid-In Capital	2,660	2,510	2,327	2,211	2,085	1,978
Retained Earnings	24,477	22,686	20,295	15,892	14,456	12,362
Treasury Stock	-4,879	-4,487	-4,424	-4,378	-3,761	-2,504
Comprehensive Income & Other	-48	-720	-676	-1,646	-64.6	488.9
Total Common Equity	22,211	19,990	17,523	12,080	12,716	12,326
Minority Interest	-	-	2	11	9.23	881.56
Shareholders' Equity	23,041	20,820	18,355	12,921	13,555	13,987
Total Liabilities & Equity	78,788	70,906	58,906	47,990	45,101	43,282
Filing Date Shares Outstanding	373.87	373.83	372.63	369.03	376.97	401.38
Total Common Shares Outstanding	373.87	374.87	371.88	368.18	376.85	405.08
Total Debt	2,728	2,891	2,882	2,877	2,851	3,454
Net Cash (Debt)	-1,745	-1,912	-1,965	-2,022	-1,992	-2,547
Net Cash Per Share	-4.57	-5.01	-5.19	-5.35	-4.98	-6.21
Book Value Per Share	59.41	53.32	47.12	32.81	33.74	30.43
Tangible Book Value	20,892	18,639	16,792	11,276	11,771	11,633
Tangible Book Value Per Share	55.88	49.72	45.15	30.63	31.23	28.72

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.